发明公开
EP1898920A1 FORMULATION COMPRISING FARNESYL DIBENZODIAZEPINONE AND A PHARMACEUTICALLY ACCEPTABLE SURFACTANT
审中-公开
配方FARNESYLDIBENZODIAZEPINON和药学上可接受的表面活性剂
- 专利标题： FORMULATION COMPRISING FARNESYL DIBENZODIAZEPINONE AND A PHARMACEUTICALLY ACCEPTABLE SURFACTANT
- 专利标题（中）： 配方FARNESYLDIBENZODIAZEPINON和药学上可接受的表面活性剂
-
申请号： EP06741586.9申请日： 2006-05-30
-
公开(公告)号： EP1898920A1公开(公告)日： 2008-03-19
- 发明人: RANGER, Maxime , ROUX, Emmanuelle , HARVEY, Michael , WHITE, Gregory, L.
- 申请人： Thallion Pharmaceuticals Inc.
- 申请人地址： 7150 Rue Alexander-Fleming Montreal, QC H4S 2C8 CA
- 专利权人： Thallion Pharmaceuticals Inc.
- 当前专利权人： Thallion Pharmaceuticals Inc.
- 当前专利权人地址： 7150 Rue Alexander-Fleming Montreal, QC H4S 2C8 CA
- 代理机构： Vossius & Partner
- 优先权： US686394P 20050602
- 国际公布： WO2006128288 20061207
- 主分类号： A61K31/5513
- IPC分类号： A61K31/5513 ; A61P35/00
摘要：
The invention relates to pharmaceutical formulations comprising a farnesyl dibenzodiazepinone compound, or an analog, or a pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutically acceptable surfactant and having improved chemical and biological properties. Such a formulation is a ready-to-use solution suitable for parenteral or non-parenteral administration or a bulk formulation for ex tempore preparation. The present invention also relates to therapeutic methods using the formulations, and methods for their preparation.
信息查询
IPC分类:
